Stay updated on Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The site’s revision identifier was updated from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-18T01:56:16.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The study page displays details for a completed Phase 2 trial of pembrolizumab plus paclitaxel for hypermutated, hormone receptor-positive metastatic breast cancer, including enrollment, study design, eligibility, and outcome measures.
    Difference
    44%
    Check dated 2026-11-11T01:10:28.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-03T23:25:59.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition from “Artificial Intelligence” to “Super Intelligence” terminology under Executive Order 14434, and the site revision advances from v3.7.1 to v3.7.2. The study record remains behind a 403 error.
    Difference
    1%
    Check dated 2026-10-20T23:07:55.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:13:59.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The 403 Forbidden error page (and the Home link) was removed, and the page now shows the standard study details layout with navigation.
    Difference
    0.5%
    Check dated 2026-09-29T23:22:01.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial page.